WHAT: A telephone press conference call today during which U.S. Rep. Mark Pocan (D-Wis.) and experts from Public Citizen’s Access to Medicines Program, Social Security Works and Indivisible will review and comment on H.R. 3, the U.S. House Democratic leadership’s long-awaited signature legislation to lower prescription drug prices.
The plan envisions direct government price negotiation with drugmakers backed by tax penalties, using prices paid in other wealthy nations as one of several reference points. The experts will discuss the plan’s major features, its capacity to generate savings and its limitations, including its limited tools to address the high and rising prices of medicines when they are first placed on market.
WHO: U.S. Rep. Mark Pocan (D-Wis.), co-chair of the Congressional Progressive Caucus
Robert Weissman, president, Public Citizen
Peter Maybarduk, director, Public Citizen’s Access to Medicines Program
Alex Lawson, executive director, Social Security Works
Angel Padilla, national policy director, Indivisible
WHEN: 1 p.m. EDT, Thursday, Sept. 19
CALL-IN NUMBER: (800) 875-3456
Verbal Passcode: DrugPrice2020